| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 28, 2026 | ±2.1% | +1.9% | over-priced |
| October 28, 2025 | ±2.1% | -2.4% | under-priced |
| July 29, 2025 | ±1.7% | +0.2% | over-priced |
| April 29, 2025 | ±2.2% | +0.8% | over-priced |
| October 29, 2024 | ±1.5% | -0.6% | over-priced |
| July 30, 2024 | ±1.7% | -0.1% | over-priced |
| April 30, 2024 | ±1.8% | +0.1% | over-priced |
| November 1, 2023 | ±1.6% | +0.9% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.44 | $10.1B | $564M |
| Q4 FY2025 | $0.52 | $10.5B | $669M |
| Q3 FY2025 | $0.57 | $9.7B | $746M |
| Q2 FY2025 | $0.49 | $9.0B | $644M |
Mondelez International, Inc. Class A (MDLZ) reports in 90 days, with the next report estimated for September 11, 2026. Across the last 8 reports, options priced an average ±1.8% earnings move while the stock actually moved 0.9% on average — the market has systematically over-priced MDLZ's earnings risk. Fundamentals into the print: EPS up 41.9% year-over-year, revenue up 8.2%. QuantLogix's live 5-factor engine currently reads MDLZ as a buy at 63/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →